Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

OptimizeRx Corporation (OPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
30.34+2.48 (+8.90%)
At close: 04:00PM EDT
30.34 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close27.86
Open28.05
Bid25.90 x 900
Ask30.31 x 900
Day's Range28.05 - 30.56
52 Week Range21.33 - 99.18
Volume429,418
Avg. Volume179,748
Market Cap539.127M
Beta (5Y Monthly)0.72
PE Ratio (TTM)452.84
EPS (TTM)0.07
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est59.25
  • GlobeNewswire

    OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership

    The latest omni-channel platform extension gives pharma access to up to 84% of prioritized HCPs on social media with content that is specific to their specialtyROCHESTER, Mich., June 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a major extension of its omni-channel platform reach through an exclusive partnership with Equals 5. The new extension is

  • InvestorPlace

    5 Small-Cap Stocks That Are Diamonds in the Rough

    Small-cap stocks have a market capitalization of between $300 million to $2 billion. These stocks are often misunderstood to be risky and speculative. However, small-cap stocks are the best way for investors to get into the market at a lower cost and without having to worry about not having enough knowledge. Small-cap stocks have the potential to outperform large-cap stocks because they tend to be more nimble and more flexible in their business models. This is because they need to compete with l

  • GlobeNewswire

    OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution

    - Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation and Persistence Platform, TelaRep is now being used by over 200,000 in-network healthcare providers (HCPs) ROCHESTER, Mich., June 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on t

Advertisement
Advertisement